Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Mulls Possibility Of Preannouncing Post-COVID Domestic Surveillance Inspections
Mar 16 2021
•
By
Joanne S. Eglovitch
FDA Considering Preannounced Inspections • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance